IPHA publishes Clinical Trials Performance Survey with steps for process improvements
Clinical trials help to bring life-changing new treatments and vaccines to patients. Today, International Clinical Trials Day, we celebrate patients, scientists and regulators who contribute to the clinical translation of innovation.
Ireland needs to get much better at doing clinical trials. As the latest IPHA Clinical Trials Performance Survey shows here, we often experience trial start-up delays and we don’t always meet recruitment commitments.
Between 2013 and 2020, Ireland attracted fewer industry-sponsored trials than Finland and Denmark, despite similar population sizes and wealth. Ireland had 371 trials compared with 1,071 for Denmark and 571 for Finland.
In 2019/2020, industry-sponsored trials dropped by 15% in Denmark and by 19% in Finland. In Ireland, the fall was 66%. COVID-19 meant fewer clinical trials in general but the falloff in Ireland is much more significant.
Process reforms are needed in the clinical trials process, including an Ireland-wide standard site contract (Clinical Trial Agreement) to reduce start-up delays, protected research time and a requirement that hospitals adhere to patient recruitment pledges.
Download the report here.